Share Capital Audit Report for Q2 ended September 2026
AAKAAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aakaar Medical Technologies filed its quarterly share capital audit report under SEBI Regulation 76 for the quarter ended September 30, 2026. Issued and listed capital stand at 1,41,72,816 equity shares of Rs 10 each (about Rs 14.17 crore). All shares are held in dematerialized form - 1,00,97,719 in CDSL and 40,75,097 in NSDL, with no physical shares. No demat or remat requests were received and no changes occurred in share capital during the quarter.
Routine quarterly compliance filing. No changes to share capital. All shares already in demat form. No material impact on shareholders.